|
|
|
Volumn 2, Issue SUPPL. 4, 1997, Pages 41-58
|
|
Drug resistance and its implications in the management of HIV infection
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1592;
ABACAVIR;
AMPRENAVIR;
ANTIVIRUS AGENT;
DELAVIRDINE;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
UNCLASSIFIED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CROSS RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MULTIDRUG RESISTANCE;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
TREATMENT FAILURE;
VIRUS GENOME;
VIRUS INFECTION;
VIRUS RESISTANCE;
|
|
EID: 0030786287
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (37)
|
|
References (125)
|
